In this subtype of lung cancer, Zavitsanou and coworkers demonstrated that KEAP1-mutant tumors were able to suppress dendritic cell and T cell responses, creating an immunosuppressive phenotype that could drive resistance to immunotherapy. This evidence concerns the gene KEAP1 and lung carcinoma.